EQ
USDEquillium Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$0.351
Máximo
$0.390
Mínimo
$0.351
Volume
0.22M
Fundamentos da empresa
Capitalização de mercado
13.8M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.36M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1
Leerink Partners analyst Thomas Smith downgrades Equillium from Outperform to Market Perform and lowers the price target from $3 to $1.
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
Treatment with itolizumab did not improve complete or overall response rates at Day 29 Itolizumab achieved statistical significance in multiple secondary endpoints demonstrating compelling clinical benefit in
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Announced topline data from the Phase 3 EQUATOR study in first-line acute graft-versus-host disease Breakthrough Therapy designation and meeting request to discuss potential for Accelerated Approval submitted to FDA,
Ações relacionadas
SNEX
StoneX Group Inc.
VSH
Vishay Intertechnology Inc.
SLP
Simulations Plus Inc.
NYMTL
New York Mortgage Trust Inc. 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock $0.01 par value per share
CRDF
Cardiff Oncology Inc.
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.